DiaMedCare
Venture-Capital-Firma, die in wachstumsstarke Technologieunternehmen investiert.
Diamond Hands Ventures
Venture-Capital-Firma, die in wachstumsstarke Technologieunternehmen investiert.
Diamond Head
Venture-Capital-Firma, die in wachstumsstarke Technologieunternehmen investiert.
Dideriksen & Company
Venture-Capital-Firma, die in wachstumsstarke Technologieunternehmen investiert.
Didi Value Partners
Venture-Capital-Firma, die in wachstumsstarke Technologieunternehmen investiert.
Dieter von Holtzbrinck Ventures

Dieter von Holtzbrinck Ventures (DvH Ventures) is an early-stage investor in Europe, focusing on partnering with passionate founders who are disrupting industries. Since 2014, they have positioned themselves as active investors, managing multiple venture capital funds from their Cologne office. Initially, DvH Ventures focused on publishing-related digital business models, leveraging the media reach of Handelsblatt, Tagesspiegel, and DIE ZEIT publishing groups to support their portfolio companies. They then expanded into fintech and insurtech investments, building a successful portfolio in those sectors. Today, DvH Ventures operates two independent early-stage investment funds. Their Digital Tech Fund (DvH Ventures Fund III) invests primarily in deep tech and education startups. In 2020, they launched a Digital Health Fund (DvH Ventures Fund IV) with a first closing of €70 million, targeting technologies that solve future healthcare challenges across Europe. DvH Ventures acts as a partner with strong entrepreneurial passion, providing expertise and networks to their portfolio companies and founders. They emphasize close and trusting interactions. Their investment approach involves taking lead positions in early-stage rounds, providing not only financial resources but also management expertise and an international investor network. Additionally, DvH Ventures offers a media-for-equity program, granting access to brands like Handelsblatt, WirtschaftsWoche, DIE ZEIT, and Apotheken Umschau to provide portfolio companies with significant reach into target markets. They are always seeking innovative ideas, even outside their defined focus areas, from compelling entrepreneurs. DvH Ventures focuses on building successful investment clusters, including digital health, education, and financial services, while remaining open to digital innovation in areas like artificial intelligence, enterprise software, the Internet of Things, big data, mobility, energy, and the future of work. The firm culture emphasizes working at eye level with founders, celebrating successes, overcoming challenges together, and operating in a fast, unbureaucratic, and highly professional manner. They commit to providing hands-on support for the growth of their portfolio companies with full entrepreneurial commitment.
DigiTx Partners
DigiTx Partners is a venture capital firm focused on investing in early-stage digital health companies aiming to solve complex challenges and inefficiencies in healthcare. They focus on companies that utilize data as fuel to generate intelligence and drive capital-efficient growth. Their investment strategy leverages deep industry expertise and an extensive network to identify and support digital health companies with high growth potential, disruptive technologies, and a clear vision for transforming the future of healthcare. The firm targets data-driven technologies that leverage proprietary data or intelligent use of public data to generate competitive insights and improve patient outcomes. They invest in companies dedicated to enhancing patient lives, with a focus on personalized medicine, data analytics, and digital therapeutics. DigiTx Partners believes in moving away from a "one-size-fits-all" mentality and towards personalized healthcare solutions that integrate biometric signals and "omics" data to tailor treatment and prevention. DigiTx also prioritizes solutions that can generate meaningful healthcare data, intelligently analyze it, and demonstrate competitive insights to improve patient and population outcomes. They foresee a future where software will be routinely prescribed to treat patients with acute and chronic conditions, investing in evidence-based and clinically validated digital interventions. They seek companies generating proprietary datasets and employing advanced analytics to drive patient outcomes. Their commercialization strategy involves understanding the broader healthcare industry relationships and appealing to multiple audiences across all stages of commercialization. They recognize gaps in existing workflows and strive to connect healthcare providers with superior solutions. DigiTx is an active investor, providing strategic and operational support to drive outsized value, and maintaining steadfast support to enable long-term success and sustainable growth.
Digital Catapult

Digital Catapult is a deep tech innovation organization focused on accelerating the practical application of advanced digital technologies to drive sustainable economic growth in the UK. They bridge the gap between industry, government, investors, and academia to unlock commercial opportunities for startups with pioneering solutions. Digital Catapult enables organizations to think differently, build resilience, and achieve success by challenging them purposefully and equipping them with the deep tech capabilities they need for the long-term. Their approach includes building UK-centric digital clean technology ecosystems, enabling twin transitions to digital and sustainable economies, and ensuring digital technology is sustainable by design.
Digital China Health
Venture-Capital-Firma, die in wachstumsstarke Technologieunternehmen investiert.
Digital Finance Group (DFG)

Digital Finance Group (DFG) is a research-driven family office founded in 2015 by James Wo, managing over $1 billion in digital assets. DFG's core investment strategy is built upon a strong conviction in Bitcoin and leverages technical research to identify and invest in protocols that are building decentralized infrastructure. They take concentrated positions, signifying a high-conviction investment approach. Unlike traditional venture capital funds, DFG operates with a permanent capital structure, enabling a multi-generational investment time horizon. This allows them to remain committed to their investments and support builders in reshaping global financial systems without the pressures of typical LP mandates and fixed exit timelines. Their investment decisions are driven by conviction and long-term value creation, allowing them to hold positions as long as necessary. DFG's investment approach is active and adaptable, involving close monitoring of the ever-changing macro-environment to dynamically optimize their strategies. Recently, they've been executing a geographical philosophy in making investment decisions, though the specifics of this philosophy aren't detailed in the provided text. The focus is on identifying top-tier teams with exceptional growth potential and securing future investments that will result in greater revenue and exceptional results in the dynamic landscape of digital assets and emerging technologies. Overall, DFG positions itself as a long-term, conviction-driven investor focused on backing foundational infrastructure and protocols within the decentralized finance ecosystem, leveraging a research-intensive approach and a permanent capital base to support long-term value creation.
Digital Genesis SICAV RAIF Fund
Venture-Capital-Firma, die in wachstumsstarke Technologieunternehmen investiert.
Digital Innovation and Growth
Venture-Capital-Firma, die in wachstumsstarke Technologieunternehmen investiert.
Digital Irish
Venture-Capital-Firma, die in wachstumsstarke Technologieunternehmen investiert.
Digital Ocean Ventures Starter

Digital Ocean Ventures Starter (DOV.VC) focuses on backing early-stage fintech and digital transformation startups, especially those leveraging AI. They seek to invest in companies that are designed for the venture path, exhibiting sharp insights, unfair distribution advantages, or defensible data that compounds over time. They prioritize understanding the founders, the customer pain points, and the business logic under pressure before making an investment. Recognizing that not every good business is suited for venture capital, they exercise selectivity. When they invest, DOV.VC commits time and attention alongside capital, acting as partners and providing skin in the game. DOV.VC believes that venture capital should genuinely help build better companies. They emphasize understanding over speed, opting to spend more time upfront evaluating the people, the problem being solved, and the scalability of the business model. They are comfortable saying no to businesses that might be good but not venture-scalable, focusing on where their capital, time, and partnership can accelerate long-term value creation. They consider themselves partners rather than just capital providers and offer hands-on support to founders through both favorable and challenging periods. This high-touch approach involves significant involvement, attention, and commitment, emphasizing a deep trust and belief in the companies they support. They invest in people they'd want to work with, focusing on real-world problems and businesses with enduring, scalable systems.
Digital Transformation Capital Partners (DTCP)

Digital Transformation Capital Partners (DTCP) is a platform focused on specialist investment strategies, driven by the conviction that rapid technology adoption fuels innovation, disrupts industries, and unlocks unprecedented wealth creation. DTCP's approach is centered on identifying and investing in transformative sectors, where digital advancements lead to lasting impact and growth. They operate across two primary investment strategies: Infra and Growth. DTCP Infra specializes in digital infrastructure investments within the European mid-market, with a focus on developing and operating essential assets like data centers, mobile towers, and fiber networks. They aim to play a vital role in driving innovation and enabling the modern digital economy by supporting the growth of these critical infrastructures. DTCP Growth partners with top enterprise SaaS entrepreneurs in Europe, the US, and Israel, focusing on growth-stage companies – scale-ups – in Cybersecurity, Vertical SaaS, DevOps, Cloud, AI, and Robotics. They aim to drive transformative growth and support their journey toward successful global expansion. DTCP also prioritizes ESG and sustainability principles, believing they are integral to creating value for investors and stakeholders by mitigating risks and capturing new opportunities. They actively address ESG matters throughout the investment cycle, adhering to the UN Principles for Responsible Investment (PRI) and reinforcing their commitment to the UN Sustainable Development Goals (SDGs). Their ESG Committee oversees the integration of ESG principles across all aspects of their operations.
Digital Transition Fund
Venture-Capital-Firma, die in wachstumsstarke Technologieunternehmen investiert.
DigitalHealth.London

DigitalHealth.London is not a traditional venture capital firm but rather an organization focused on transforming health and care through digital innovation in London's NHS and social care system. Their strategy involves connecting NHS staff, digital health companies, and academics to facilitate the adoption of digital technologies. They achieve this by providing various programs designed to advise, mentor, educate, and connect digital health leaders and equip them with necessary tools to address challenges within the NHS. DigitalHealth.London supports companies throughout their life cycle, from early-stage companies launching their products to more mature companies speeding up adoption within the NHS and scaling internationally. A key component is also helping companies generate necessary evidence to validate their solutions to the NHS.
Dimension
Venture-Capital-Firma, die in wachstumsstarke Technologieunternehmen investiert.
Dimerent
Venture-Capital-Firma, die in wachstumsstarke Technologieunternehmen investiert.
Dinero Holding
Venture-Capital-Firma, die in wachstumsstarke Technologieunternehmen investiert.
Direkt Gruppe

Based solely on the provided website content, Direkt Gruppe's investment thesis is not explicitly stated. However, the website features Skaylink, a cloud solutions and digital transformation company. It appears Direkt Gruppe's strategy may involve investing in and supporting companies that provide cloud strategy, security, compliance, and managed services. Skaylink's focus is on helping businesses navigate their cloud journey, offering expertise in infrastructure, application development, migration, modernization, and workforce empowerment. They work across various hyperscaler platforms and geographic regions. The mention of case studies involving Henkel, BMW Group, KWS, and Continental suggests a focus on helping large enterprises with their digital transformation initiatives using cloud technologies. Skaylink emphasizes security and compliance as integral to innovation. Without additional information, it's impossible to definitively assess the broader Direkt Gruppe investment approach. The partnership with Skaylink signals that Direkt Gruppe values companies with strong technical expertise, a global reach, and a commitment to helping businesses leverage cloud technologies for growth and innovation.
Direttissima Growth Partners
Direttissima Growth Partners is a European technology investment firm focused on growth financing. They target companies with proven product-market fit and a minimum revenue of €5 million, emphasizing sound unit economics and asset-light businesses. They aim to support entrepreneurs in reaching their business potential by providing strategic clarity and building high-performance teams.
Discovery Park Ventures

Discovery Park Ventures, based in Kent, UK, is a science and technology park designed to foster innovation and growth for businesses ranging from startups to multinational corporations. They provide state-of-the-art labs, flexible office spaces, and comprehensive support to help companies transform ideas into successful commercial innovations. The park aims to be a hub for interdisciplinary innovation and a thriving community for visionary entrepreneurs, particularly within the life sciences and advanced manufacturing sectors. Their strategy includes attracting businesses working at the edge of new technologies and fostering scientific collaboration. The focus on the Sandwich-based site, which has a strong heritage in pharmaceutical research and development (previously a Pfizer site), positions Discovery Park as a key player in the UK's science and technology landscape. They strive to become a leader in advanced, digitally enabled manufacturing for future healthcare systems. The firm runs programs such as Discovery Spark, aimed at early-stage founders to refine pitches and become investor-ready. They also promote the development of a manufacturing village to leverage the site's manufacturing expertise and address the need for life sciences manufacturing capacity. Furthermore, the upcoming Carbon 6 Academy of Science shows commitment to nurturing future talent within the science and technology sectors. Discovery Park leverages its location within the Golden Triangle extension to provide access to resources and opportunities, coupled with flexible expansion options and open spaces to inspire creativity. The emphasis on sustainability and community-building makes it an attractive location for businesses seeking both physical space and a supportive ecosystem. The park also aims to capitalize on its Life Sciences Opportunity Zone designation, further enhancing its appeal to companies in the life sciences sector.
Discovery Ventures

Discovery Ventures is a healthcare-focused venture capital firm with a 15+ year history of investing in and partnering with the next generation of biotech and healthcare leaders. They aim to accelerate biomedical innovation by combining deep technical expertise, smart capital, and a global network. The firm focuses on groundbreaking biotech companies with the potential to drive life-changing healthcare innovations and exceptional growth. They provide both capital and strategic guidance to help scale next-generation technologies in areas such as Artificial Intelligence, Gene Therapy, Nanotechnology, and Bionics. They emphasize their ability to navigate the unique challenges of Next Generation Biotechnology and AI-driven discovery, citing their legacy of clinical success and long-term approach to building enduring companies. They have established partnerships with leading biotech venture capital firms across the US and Europe, leveraging expertise in Artificial Intelligence, Gene Therapy, Advanced Cell therapy, Bionics, Tissue Engineering, and Nanotechnology.